D. E. Shaw & Co., Inc. Cytosorbents Corp Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$3.77 - $7.73 $191,391 - $392,428	-50,767 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.61 - $5.22 $183,268 - $265,003	50,767 New	50,767 $195,000
Q3 2019 Nov 14, 2019	SELL	$4.33 - $7.63 $107,643 - $189,681	-24,860 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.78 $147,171 - $193,410	24,860 New	24,860 $164,000
Q1 2019 May 15, 2019	SELL	$6.82 - $8.56 $147,196 - $184,750	-21,583 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$7.05 - $12.64 $152,160 - $272,809	21,583 New	21,583 $174,000
Q3 2018 Nov 14, 2018	SELL	$10.95 - $14.8 $200,932 - $271,580	-18,350 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$6.9 - $12.35 $126,615 - $226,622	18,350 New	18,350 $209,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.